Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. - Wikidata - awgldk - TriplyDB

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

http://www.wikidata.org/entity/Q33372701

about

Contemporary management of primary immune thrombocytopenia in adults Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.Chronic immune stimulation and subsequent Waldenström macroglobulinemia Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease.Pathobiology of secondary immune thrombocytopenia.Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.Toxicities of the thrombopoietic growth factors Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma.A difficult diagnosis of Hodgkin lymphoma due to immune thrombocytopenia Hodgkin lymphoma: an update on its biology with new insights into classification.Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case-control study in Connecticut and Massachusetts.Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.Malignancy in systemic lupus erythematosus: what have we learned?Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease The epidemiology and pathogenesis of neoplasia in the small intestine.Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort study Genomic expression profiling and bioinformatics analysis of pancreatic cancer Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood.Autoimmunity and lymphomagenesis.Cancer in first-degree relatives of people with celiac disease Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma Epstein-Barr-Virus-Infected CD15 (Lewis X)-Positive Hodgkin-Lymphoma-Like B Cells in Patients with Rheumatoid Arthritis.Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.Autoimmune disease and risk for Parkinson disease: a population-based case-control study.Autoimmunity and hematologic malignancies: associations and mechanisms.SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.Familial associations of lymphoma and myeloma with autoimmune diseases.

P2860

Q26853680-6665A8F4-3546-4369-9960-A08E01897D2B Q27687340-CB1D202F-AC26-438F-B75D-011F296A041B Q28294893-CB2128E1-2B12-49C3-A8D8-A21A8F4EC5D2 Q28943266-821C10DF-9CD2-4029-BB2C-191CC07EE210 Q33379066-14B6BA46-2C7D-4F90-A909-06706E2A00FF Q33383468-F63F573B-1B67-4DB7-B2D6-C7CA398CD586 Q33388187-12802B99-2E49-4BA4-9A37-8A0F7C0FB619 Q33390645-2D92B2B5-8141-461D-A7C6-67A2F0D0D265 Q33399359-0B03FD48-A117-44C5-939D-87F27026D983 Q33421695-EE661452-5624-40B4-A840-FA3C50D1C7E8 Q33588862-08988D53-82FB-45D6-97F8-415FC595D0FB Q33709207-C67C81C6-74F0-4A39-9B24-38BF1EB55C3F Q33803072-85C21495-5D75-4E1C-AF83-068A9DF8835D Q34077378-AE322F23-3648-435C-8816-66461A63040D Q34087859-A722CA12-312E-41D2-9D44-9B386B368CB7 Q34446894-6AD5EF12-6101-456B-BDFE-99DD1F984B6A Q34477808-34BA42F5-23A8-4292-B6C1-60E39519F206 Q34601452-7C338AEF-F0F2-4756-A560-F13EF71D513D Q34637366-B739502D-99C7-46A8-8E31-EC525F638F9A Q35112330-DF8664CF-320B-4CCF-AB7C-86A50FA2DA68 Q35120199-49D3957A-CCCA-44D9-AE29-484D5255D065 Q35582562-92BF0F6D-817B-4FBB-A41D-3442BD723092 Q35608156-0EB9EE2A-F4FA-4B04-AABD-6DA1921A744C Q35642807-BDBA3088-5DB0-4C1D-B659-454F428376E2 Q35914916-22BD71A6-0883-4037-A063-6FC5888681AF Q35919898-8AD80BF9-A35D-4EAA-A021-5B8505E3FA25 Q36089344-DA473C70-A899-4EE7-BAD1-336A7D0C1003 Q36375393-D851CD1C-323C-46DF-8698-59DC66E6F525 Q36606583-6736EC33-7405-4809-9A87-8D5F55AF982C Q37152267-E040E93D-0971-4891-8771-76474041BDFA Q37176093-4A947D8F-3540-4541-B705-49B311E7D3E0 Q37218079-58A2C22F-CC5F-4DDA-BDE4-90FBD4FBC686 Q37219761-FDCEA07F-6F1F-4D70-9777-660E54C65FF0 Q37286985-C859B6DA-58E7-458F-B17E-DEC84C7048B8 Q37350444-95AFE7DF-346B-42C0-8A67-ED25E8B6F6A2 Q37406801-4D4EE772-365C-48A8-860E-57FC81B51A1A Q37425099-E226C288-5466-4E8E-AAE7-1D64C09C4B71 Q37448413-AD78E7F7-083F-40D3-9E94-82CCD3FF995C Q37615218-1A8D4325-161F-46B5-951A-3ECBCD9F4954 Q37634748-D9ADB8EB-41EB-4915-AD0C-E53CEB739E7B

P2860

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

http://www.wikidata.org/entity/Q33372701

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@ast

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@en

type

label

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@ast

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@en

prefLabel

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@ast

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@en

P1433

Q33372701-E4A3177A-F917-466E-91FD-434B54E6AC8F

P1476

Q33372701-D6E53D9E-B9C6-4E14-8B74-4074D45A7520

P2093

Q33372701-2612E9F4-9F81-4F20-B538-E2BC92A78724

Q33372701-3B5F4309-7DDB-4355-B447-BFF5B8AD7A89

Q33372701-7A8696CE-5092-491B-8781-A9889C04270A

Q33372701-897A83BC-991E-4577-85BC-0D0CBAF23DB9

Q33372701-D53C6D8E-6488-4A22-B3D1-FCA0B345A54E

Q33372701-D88D7058-BBCE-4267-9711-6459EFE96D9A

Q33372701-DA1C5831-C1CD-4605-8BBE-3F5BA18DA7F8

P2860

Q33372701-06B4333E-193A-4091-89E6-F2C360B23FBE

Q33372701-0C0FC12C-B49D-476E-A470-231CB0B50305

Q33372701-188EDB1E-F95A-43AA-BC0E-9E9E42D3BC09

Q33372701-1FC3A91D-6F60-4065-AEB1-D619965CA03A

Q33372701-29E36354-E27A-47F0-BAAE-570FCECD9C26

Q33372701-31BC6D04-4A64-4DEA-A5DD-C7FA2E647DEC

Q33372701-3690A094-B855-4CEB-9606-3FE6ADCE2036

Q33372701-385B965C-FE74-4C6D-8DF4-16A4DADC9307

Q33372701-3A33AE61-B088-4B03-9B3A-C535C60C7D0C

Q33372701-43217C41-C1B6-4F66-8FBB-5609010A5EDB

P304

Q33372701-89AD1110-3F5E-4CAB-BB3F-63CF1EDC579A

P31

Q33372701-36099A9D-C160-4E37-AA27-FE032A8544C6

P356

Q33372701-0AB6BDB9-90E1-4301-B6C1-C1DBD4F63A5D

P407

Q33372701-515F7D64-F160-4CDD-B539-86B3CC23807A

P433

Q33372701-327866A3-B4F7-4AEE-9FF2-5FC1696F9B5A

P478

Q33372701-239DB286-DBD4-46BE-8C28-96C05D7CC1E5

P50

Q33372701-665D0FF1-FD4E-4A26-8DAA-AD1B287F669F

Q33372701-79C17196-904E-4BF8-A792-D089DF26CFD0

Q33372701-AF761542-60F3-4672-ABAF-B019AB704C4F

Q33372701-DB64AFFB-AD71-489B-BAD9-AD20834627A1

P577

Q33372701-28D5DED3-F436-4165-9CE0-A8EC067B83BE

P5875

Q33372701-A44389ED-490D-4A47-BCE5-1676B52B2860

P698

Q33372701-58EDA757-81C5-4B64-BDD3-25BF7B83C718

P356

P1433

Journal of the National Cancer Institute

P1476

Autoimmunity and susceptibilit ...... -control study in Scandinavia.

@en

P2093

Eric A Engels

http://www.w3.org/2001/XMLSchema#string

Gloria Gridley

http://www.w3.org/2001/XMLSchema#string

Kimberly F Kerstann

http://www.w3.org/2001/XMLSchema#string

Lynn R Goldin

http://www.w3.org/2001/XMLSchema#string

Martha S Linet

http://www.w3.org/2001/XMLSchema#string

Ruth M Pfeiffer

http://www.w3.org/2001/XMLSchema#string

William Wheeler

http://www.w3.org/2001/XMLSchema#string

P2860

Familial risk of cancer: data for clinical counseling and cancer genetics.

Increased risk for cancer following sarcoidosis.

Inflammatory bowel disease: the role of environmental factors.

Epidemiology and etiology of Hodgkin's lymphoma.

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Non-Hodgkin's lymphoma in systemic lupus erythematosus

Risk of malignant neoplasms in patients with pulmonary sarcoidosis

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Hodgkin's disease: case control epidemiological study in Yorkshire.

Incidence of familial Hodgkin's disease.

P304

1321-1330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ361

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Lene Mellemkjaer

Jørgen H Olsen

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6809683

http://www.w3.org/2001/XMLSchema#string

P698

16985251

http://www.w3.org/2001/XMLSchema#string